Patent Application
20160183863
1. Field of the Invention
The present invention relates to a detecting device, and relates particularly to a detecting device that is used for measuring physiological values.
2. The Prior Arts
In the present day, modern people are often busy with work. As such, the average age of marriage increases continuously, and the plans of starting a family are often bothersome to newly married couples who are frequently busy. Women from the traditional Chinese societies face greater pressure compared to men when it comes to having children. Therefore, how women control the ovulation period which is key to pregnancy has become very important. Accordingly, ovulation test strips or basic thermometers are provided by the market, in order to help women control the date of conception.
Generally, during the menstrual cycle of women, the level of luteinizing hormone (LH) begins to increase, reaches a peak on the day before ovulation, and the level of LH decreases rapidly after ovulation. The follicle-stimulating hormone (FSH) will reach a high point before ovulation, after which the level of FSH will begin to decrease; the level of FSH will reach a low point around three days before ovulation, and the level of FSH reaches another high point on the day before ovulation. In terms of basic body temperature, the basic body temperature of the general adult woman decreases by 0.1-0.2° C. before ovulation, and the basic body temperature increases by 0.3-0.5° C. after ovulation. A temperature difference of 0.4-0.7° C. exists before and after ovulation. Accordingly, LH agents, FSH agents and basic thermometers are provided in the market for the adult women. However, no matter whether it is the LH agent, FSH agent or the basic thermometer, there are still disadvantages associated with these.
The LH agent is used for detecting the changes in the level of LH, but as shown in
The levels of FSH that are detected by the FSH agent will have two high points before ovulation. However, the difference between the high point and the low point in the FSH levels is not as obvious as the changes in the levels of the LH. As such, there are difficulties when interpreting the date of ovulation, and difficulties are also present when making judgments on the day of ovulation.
The basic thermometer makes use of the temperature difference of 0.4-0.7° C. at both before and after ovulation to calculate the date of ovulation. However, since the human body temperature changes in accordance with conditions of the body, such as in situations when the person has a cold or fever, the basic temperature of the body also changes accordingly. As such, if the ovulation date is judged only by using the method of measuring the basic body temperature, then this judgment is associated with errors.
One of the objectives of the present invention is to provide a physiological detecting device for the detection of at least one physiological hormone, in order to increase the degree of accuracy while predicting the time of ovulation during the menstrual cycle of women. The physiological detecting device of the present invention includes a measuring unit, and may include a test strip end, a test strip reaction zone and a connecting end; whereby the test strip end may include at least one test strip for taking a sample of a test solution containing at least one physiological hormone. The test strip reaction zone may react with the at least one physiological hormone that is on the test strip end. The engaging portion may be engaged to the connecting end of the measuring unit in a first instance, and may be engaged to the test strip end of the measuring unit in a second instance. In the second instance, the engaging portion may be engaged to the test strip end of the measuring unit, for pushing the test solution sampled on the test strip reaction zone for the test strip reaction to be performed.
Preferably, the first instance may refer to the time that the physiological detecting device is beginning to be used, and the second instance may refer to the time needed for the physiological detecting device to detect the test solution.
Preferably, the test solution may be urine from a human body.
Preferably, the engaging portion may include a handheld anti-slip portion, whereby the handheld anti-slip portion may be an anti-slip handle.
Preferably, the test strip end may include a first test strip and a second test strip, to correspondingly detect a first physiological hormone and a second physiological hormone.
Preferably, the test strip reaction zone may include a first detecting line, a second detecting line and a reference line; the first detecting line may react with the first physiological hormone that is detected on the first test strip, the second detecting line may react with the second physiological hormone that is detected on the second test strip.
Preferably, the first detecting line and the second detecting line may present a negative reaction or a positive reaction respectively corresponding to the first physiological hormone and the second physiological hormone.
Preferably, the first physiological hormone may be Follicle-stimulating hormone (FSH), and the first test strip may be FSH-test strip.
Preferably, the second physiological hormone may be Luteinizing hormone (LH), and the second test strip may be LH-test strip.
Preferably, the test strip reaction zone may be covered by a plastic housing.
The present invention can be understood in more detail by reading the subsequent detailed description in conjunction with the examples and references made to the accompanying drawings, wherein:
The present invention may be embodied in various forms and the details of the preferred embodiments of the present invention will be described in the subsequent content with reference to the accompanying drawings. The drawings (not to scale) depict only the preferred embodiments of the invention and shall not be considered as limitations to the scope of the present invention. Modifications of the shape of the present invention shall be considered within the spirit of the present invention.
It should be noted that the structures, proportions, sizes and the like of the drawings of the current specification are only for depicting the disclosures of the present invention, to enable easy reading and understanding by persons skilled in the art, and these are not meant to be conditions that limit the present invention. As such, the drawings are not technologically meaningful. Any modifications of the structure, proportion relationships or any adjustments of the sizes should fall within the scope that is covered by the technical content of the present invention, without affecting the effects produced by the present invention and without affecting the goals of the present invention.
First of all, referring to
In addition, as shown in
In accordance with a preferred exemplary embodiment of the present invention, and referring to
In accordance with a preferred exemplary embodiment of the present invention, the engaging portion 12 may include a handheld anti-slip part 121, which is to enable the handle to have an anti-slip function, but is not limited to this.
In accordance with a preferred exemplary embodiment of the present invention, the test solution 2 of the present invention may be urine from a human body.
In accordance with a preferred exemplary embodiment of the present invention, the test strip end 111 may include a first test strip 111a and a second test strip 111b, which may be for correspondingly detecting the first physiological hormone and the second physiological hormone. The test strip reaction zone 112 may include a first detecting line 112a, a second detecting line 112b, as well as a reference line 112c. The first detecting line 112a may react with the first physiological hormone that is detected by the first test strip 111a, the second detecting line 112b may react with the second physiological hormone that is detected by the second test strip 111b. The first detecting line 112a and the second detecting line 112b may present a negative reaction or a positive reaction respectively corresponding to the first physiological hormone and the second physiological hormone detected.
In accordance with a preferred exemplary embodiment of the present invention, the first physiological hormone may be Follicle-stimulating hormone, FSH; the first test strip 111a may be FSH-test strip; the second physiological hormone may be Luteinizing hormone, LH; and the second test strip 111b may be LH-test strip.
Whereby, the test strip reaction zone 112 may be covered by a plastic housing, but is not limited to this.
Although the present invention has been described with reference to the preferred embodiments, it will be understood that the invention is not limited to the details described thereof. Various substitutions and modifications have been suggested in the foregoing description, and others will occur to those of ordinary skill in the art. Therefore, all such substitutions and modifications are intended to be embraced within the scope of the invention as defined in the appended claims.
| Number | Date | Country | Kind |
|---|---|---|---|
| 104205659 | Apr 2015 | TW | national |
This application claims priority benefits of U.S. Provisional Patent Application No. 62/098,692 filed on Dec. 31, 2014 and Taiwanese Patent Application No. 104205659 filed on Apr.15, 2015, which are hereby incorporated by reference in their entirety.
| Number | Date | Country | |
|---|---|---|---|
| 62098692 | Dec 2014 | US |
